BURLINGTON, Mass. & OXFORD, England--(BUSINESS WIRE)--Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced that presentations related to the clinical use of fluciclovine F 18 injection will be occurring at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI), from June 23 – 26, 2018 in Philadelphia, Pa. In addition, a special program led by SNMMI, “Fluciclovine Live Reader Training,” will be held immediately prior to the Annual Meeting. The oral and poster presentations highlighting ongoing investigations with fluciclovine F 18 are listed below.


ORAL PRESENTATION



Tuesday, June 26, 2018

Session Title:
SS54: Prostate Cancer Imaging II

Presentation Title:
18F-Fluciclovine PET/CT in patients with biochemical recurrence of prostate cancer: Impact on management and associations of clinical variables with scan findings

Presenter: Austin R. Pantel, MD on behalf of the LOCATE study group, Hospital of the University of Pennsylvania
Session Time: 8:00 AM – 9:30 AM ET
Presentation Time: 9:00 – 9:10 AM ET
Location: Room 107AB
Publication No: 457

POSTER PRESENTATIONS


Monday, June 25, 2018

Poster Title:
The role of fluciclovine (18F) PET/CT directed, 3D ultrasound-guided fusion targeted biopsy in the detection of biochemically recurrent prostate cancer*

Session Title: MTA 1: Prostate Posters
Presenter: Olayinka Abiodun-Ojo, MD, Emory University
Presentation Time: 3:00 – 4:30 PM ET
Location: Exhibit Hall C
Publication No.: 1481

Poster Title:
Think outside the box: tackling fluciclovine PET-CT with challenging extraprostatic findings

Session Title: MTA 1: Educational Exhibits
Presenter: Yoram Baum, MD, Emory University
Presentation Time: 3:00 – 4:30 PM ET
Location: Exhibit Hall C
Publication No.: 1164

Poster Title:
Probability of a positive F-18 fluciclovine scan based on level of PSA

Session Title: MTA 1: Prostate Posters
Presenter: William C. Lavely, MD, Northside Radiology Associates
Presentation Time: 3:00 – 4:30 PM ET
Location: Exhibit Hall C
Publication No.: 1447

Poster Title:
Utilization of F-18 fluciclovine PET/CT for initial staging of prostate carcinoma*

Session Title: MTA 1: Prostate Posters
Presenter: William C. Lavely, MD, Northside Radiology Associates
Presentation Time: 3:00 – 4:30 PM ET
Location: Exhibit Hall C
Publication No.: 1439

Poster Title:
Factors influencing the positivity rate of commercial 18F-Fluciclovine PET/CT imaging in men with suspected recurrent prostate cancer

Session Title: MTA 1: Prostate Posters
Presenter: Petra Lovrec, MD, Loyola University Medical Center

Molecular Imaging Homepage